Both in Pharmaceuticals
SELLAS Life Sciences Group vs Braveheart Bio
Over the past year SLS returned −20.8% and BRVE returned −24.5%; their daily moves had a correlation of 0.11.
SLS −20.8% BRVE −24.5%Growth of $1, one year, split-adjusted
| Metric | SLS | BRVE |
|---|---|---|
| Price | $9.14 | $20.11 |
| Market cap | $1.85B | $1.81B |
| Today | +3.04% | −6.01% |
| 1 month | −19.4% | +1.6% |
| 6 months | +77.5% | — |
| Year to date | +142.4% | — |
| 1 year | +410.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $138.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | — |
| Short % of float | 27.0% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).